FDA Genetic Array Submissions Guidance Dovetails With NCCLS Effort

FDA's guidance on "Pharmacogenetic Tests and Genetic Tests for Heritable Markers," to be issued by year-end, will exclude gene expression arrays, according to the agency

More from Archive

More from Medtech Insight